Derwent London Plc (DLN) is a leading reit-office business based in the UK. It opened the day at 3114p after a previous close of 3110p. During the day the price has varied from a low of 3002p to a high of 3132p. The latest price was 3020p (25 minute delay). Derwent London is listed on the London Stock Exchange (LSE) and employs 135 staff. All prices are listed in pence sterling.
Since the stock market crash in March caused by coronavirus, Derwent London's share price has had significant negative movement.
Its last market close was 2710p, which is 36.71% down on its pre-crash value of 4282p and 10.07% up on the lowest point reached during the March crash when the shares fell as low as 2462p.
If you had bought £1,000 worth of Derwent London shares at the start of February 2020, those shares would have been worth £724.08 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £653.65.
|52-week range||2334p - 4303.907p|
|50-day moving average||3162.2942p|
|200-day moving average||2874.6338p|
|Wall St. target price||3138.13p|
|Dividend yield||0.73p (2.38%)|
|Earnings per share (TTM)||126.7p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-01-15)||-7.59%|
|1 month (2020-12-23)||-2.52%|
|3 months (2020-10-23)||8.17%|
|6 months (2020-07-23)||5.82%|
|1 year (2020-01-23)||-26.77%|
|2 years (2019-01-23)||-0.26%|
|3 years (2018-01-23)||1.34%|
|5 years (2016-01-22)||-6.96%|
Valuing Derwent London stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Derwent London's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Derwent London's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Derwent London shares trade at around 24x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Derwent London's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £144.2 million.
The EBITDA is a measure of a Derwent London's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£238.8 million|
|Operating margin TTM||60.09%|
|Gross profit TTM||£182.8 million|
|Return on assets TTM||1.6%|
|Return on equity TTM||3.09%|
|Market capitalisation||£3.5 billion|
TTM: trailing 12 months
Dividend payout ratio: 3070.87% of net profits
Recently Derwent London has paid out, on average, around 3070.87% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.38% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Derwent London shareholders could enjoy a 2.38% return on their shares, in the form of dividend payments. In Derwent London's case, that would currently equate to about 0.73p per share.
Derwent London's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 10 September 2020 (the "ex-dividend date").
Derwent London's shares were split on a 2:1 basis on 13 June 1994. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Derwent London shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Derwent London shares which in turn could have impacted Derwent London's share price.
Over the last 12 months, Derwent London's shares have ranged in value from as little as 2334p up to 4303.907p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Derwent London's is 0.7163. This would suggest that Derwent London's shares are less volatile than average (for this exchange).
Derwent London plc owns 83 buildings in a commercial real estate portfolio predominantly in central London valued at £5.4 billion (including joint ventures) as at 30 June 2020, making it the largest London-focused real estate investment trust (REIT). Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via development or refurbishment, effective asset management and capital recycling. We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or the Tech Belt. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design. Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing. As part of our commitment to lead the industry in mitigating climate change, in October 2019, Derwent London became the first UK REIT to sign a Green Revolving Credit Facility. At the same time, we also launched our Green Finance Framework and signed the Better Buildings Partnership's climate change commitment. The Group is a member of the 'RE100' which recognises Derwent London as an influential company, committed to 100% renewable power by purchasing renewable energy, a key step in becoming a net zero carbon business. Derwent London is one of only a few property companies worldwide to have science-based carbon targets validated by the Science Based Targets initiative (SBTi). Landmark schemes in our 5.6 million sq ft portfolio include 80 Charlotte Street W1, Brunel Building W2, White Collar Factory EC1, Angel Building EC1, 1-2 Stephen Street W1, Horseferry House SW1 and Tea Building E1. In 2019, the Group won several awards including EG Offices Company of the Year, the CoStar West End Deal of the Year for Brunel Building, Westmin
Find out more about the London Stock Exchange, what companies are listed on it and how to invest in the largest exchange in Europe.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.